Private Capital Management (Florida)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Capital Management (Florida)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,402	Closed	-$2M	–	64
2015 Q4	$2M	Sell	14,402 -275	-2%	-$38.1K	0.25%	57
2015 Q3	$1.97M	Hold	14,677	–	–	0.23%	57
2015 Q2	$2.21M	Sell	14,677 -360	-2%	-$51.5K	0.24%	58
2015 Q1	$2.03M	Sell	15,037 -150	-1%	-$18.6K	0.23%	55
2014 Q4	$1.83M	Hold	15,187	–	–	0.2%	63
2014 Q3	$1.72M	Sell	15,187 -865	-5%	-$102K	0.2%	65
2014 Q2	$1.92M	Sell	16,052 -400	-2%	-$48.8K	0.22%	64
2014 Q1	$2.11M	Hold	16,452	–	–	0.27%	62
2013 Q4	$2.03M	Hold	16,452	–	–	0.25%	62
2013 Q3	$1.93M	Hold	16,452	–	–	0.18%	62
2013 Q2	$1.85M	Buy	+16,452	New	+$1.93M	0.17%	63

Other funds holding BIO

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return